Growth inhibition of breast cancer cells by Grb2 downregulation is correlated with inactivation of mitogen-activated protein kinase in EGFR, but not in ErbB2, cells

Increased breast cancer growth has been associated with increased expression of epidermal growth factor receptor (EGFR) and ErbB2 receptor tyrosine kinases (RTKs). Upon activation, RTKs may transmit their oncogenic signals by binding to the growth factor receptor bound protein-2 (Grb2), which in turn binds to SOS and activates the Ras/Raf/MEK/mitogen-activated protein (MAP) kinase pathway. Grb2 is important for the transformation of fibroblasts by EGFR and ErbB2; however, whether Grb2 is also important for the proliferation of breast cancer cells expressing these RTKs is unclear. We have used liposomes to deliver nuclease-resistant antisense oligodeoxynucleotides (oligos) specific for the GRB2 mRNA to breast cancer cells. Grb2 protein downregulation could inhibit breast cancer cell growth; the degree of growth inhibition was dependent upon the activation and/or endogenous levels of the RTKs. Grb2 inhibition led to MAP kinase inactivation in EGFR, but not in ErbB2, breast cancer cells, suggesting that different pathways might be used by EGFR and ErbB2 to regulate breast cancer growth.

[1]  A. Tari,et al.  Inhibition of Grb2 and Crkl proteins results in growth inhibition of Philadelphia chromosome positive leukemic cells. , 1997, Biochemical and biophysical research communications.

[2]  J. Farndon,et al.  Epidermal growth factor receptors in breast cancer: association with early relapse and death, poor response to hormones and interactions with neu. , 1989, Journal of steroid biochemistry.

[3]  J. Downward,et al.  Autophosphorylation sites on the epidermal growth factor receptor , 1984, Nature.

[4]  T. Pawson,et al.  The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1 , 1993, Nature.

[5]  A. Ullrich,et al.  The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling , 1992, Cell.

[6]  G. Rubin,et al.  Ras1 and a putative guanine nucleotide exchange factor perform crucial steps in signaling by the sevenless protein tyrosine kinase , 1991, Cell.

[7]  T Pawson,et al.  The human GRB2 and Drosophila Drk genes can functionally replace the Caenorhabditis elegans cell signaling gene sem-5. , 1993, Molecular biology of the cell.

[8]  Cori Bargmann,et al.  The neu oncogene encodes an epidermal growth factor receptor-related protein , 1986, Nature.

[9]  J. Downward,et al.  Epidermal growth factor regulates the exchange rate of guanine nucleotides on p21ras in fibroblasts , 1993, Molecular and cellular biology.

[10]  D. Bowtell,et al.  Identification of murine homologues of the Drosophila son of sevenless gene: potential activators of ras. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Michael J. Fry,et al.  Phosphatidylinositol-3-OH kinase direct target of Ras , 1994, Nature.

[12]  I. Pastan,et al.  Epidermal-growth-factor-dependent transformation by a human EGF receptor proto-oncogene. , 1987, Science.

[13]  S. Bates,et al.  Anti-epidermal growth factor receptor antibodies inhibit the autocrine-stimulated growth of MDA-468 human breast cancer cells. , 1989, Molecular endocrinology.

[14]  M. Hung,et al.  Suppressed transformation and induced differentiation of HER-2/neu-overexpressing breast cancer cells by emodin. , 1995, Cancer research.

[15]  W. McGuire,et al.  Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. , 1987, Science.

[16]  A. Weiss,et al.  Uncoupling of nonreceptor tyrosine kinases from PLC-gamma1 in an SLP-76-deficient T cell. , 1998, Science.

[17]  Nanxin Li,et al.  BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein , 1993, Cell.

[18]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[19]  M N Pollak,et al.  MDA-468, a human breast cancer cell line with a high number of epidermal growth factor (EGF) receptors, has an amplified EGF receptor gene and is growth inhibited by EGF. , 1985, Biochemical and biophysical research communications.

[20]  B. Angus,et al.  Epidermal growth factor receptor (EGFr) status associated with failure of primary endocrine therapy in elderly postmenopausal patients with breast cancer. , 1988, British Journal of Cancer.

[21]  A. Ullrich,et al.  Identification of autophosphorylation sites of HER2/neu. , 1990, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[22]  J. Downward,et al.  Activation of phosphoinositide 3‐kinase by interaction with Ras and by point mutation. , 1996, The EMBO journal.

[23]  G. Zon,et al.  Phosphatidylinositol-3 kinase activity is regulated by BCR/ABL and is required for the growth of Philadelphia chromosome-positive cells. , 1995, Blood.

[24]  R. Treisman,et al.  Regulation of transcription by MAP kinase cascades. , 1996, Current opinion in cell biology.

[25]  M. Greene,et al.  neu(c-erbB-2/HER2) and the epidermal growth factor receptor (EGFR) in breast cancer. , 1993, Pathobiology : journal of immunopathology, molecular and cellular biology.

[26]  M. Koegl,et al.  The phosphatidylinositol 3-kinase alpha is required for DNA synthesis induced by some, but not all, growth factors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[27]  L. Norton,et al.  Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies. , 1993, Journal of the National Cancer Institute.

[28]  T. Pawson,et al.  Molecular cloning of the mouse grb2 gene: differential interaction of the Grb2 adaptor protein with epidermal growth factor and nerve growth factor receptors , 1993, Molecular and cellular biology.

[29]  Tony Pawson,et al.  Protein modules and signalling networks , 1995, Nature.

[30]  D. Pinkel,et al.  ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[31]  A. Ullrich,et al.  Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[32]  A. Ullrich,et al.  Growth factor signaling by receptor tyrosine kinases , 1992, Neuron.

[33]  G. Rubin,et al.  An SH3-SH2-SH3 protein is required for p21 Ras1 activation and binds to sevenless and Sos proteins in vitro , 1993, Cell.

[34]  J. Noel,et al.  Dimerization-induced inhibition of receptor protein tyrosine phosphatase function through an inhibitory wedge. , 1998, Science.

[35]  理 鶴田,et al.  Materials for Seminars , 1998 .

[36]  C R King,et al.  erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells. , 1987, Science.

[37]  Julian Downward,et al.  Epidermal growth factor regulates p21 ras through the formation of a complex of receptor, Grb2 adapter protein, and Sos nucleotide exchange factor , 1993, Cell.

[38]  K D Paull,et al.  Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. , 1998, Science.

[39]  W. Fantl,et al.  Ras-dependent induction of cellular responses by constitutively active phosphatidylinositol-3 kinase. , 1995, Science.

[40]  M. Hung,et al.  Dominant-negative Mutants of Grb2 Induced Reversal of the Transformed Phenotypes Caused by the Point Mutation-activated Rat HER-2/Neu(*) , 1995, The Journal of Biological Chemistry.

[41]  Nanxin Li,et al.  Guanine-nucleotide-releasing factor hSos1 binds to Grb2 and links receptor tyrosine kinases to Ras signalling , 1993, Nature.

[42]  Joseph Schlessinger,et al.  Signal transduction by receptors with tyrosine kinase activity , 1990, Cell.

[43]  T. Yamamoto,et al.  The product of the human c-erbB-2 gene: a 185-kilodalton glycoprotein with tyrosine kinase activity. , 1986, Science.

[44]  U. Banerjee,et al.  The Son of sevenless gene product: a putative activator of Ras. , 1992, Science.

[45]  H. Horvitz,et al.  C. elegans cell-signalling gene sem-5 encodes a protein with SH2 and SH3 domains , 1992, Nature.

[46]  J. Schlessinger,et al.  Hierarchy of binding sites for Grb2 and Shc on the epidermal growth factor receptor , 1994, Molecular and cellular biology.